Adalimumab is an anti-inflammatory drug used to treat rheumatoid arthritis, Chron’s disease and other autoimmune diseases that cause severe inflammation. This medication doesn’t cure these conditions, but it can reduce painful symptoms associated with these conditions.
Adalimumab has been associated with tuberculosis, a potentially fatal lung disease, in some patients. Patients need to have a tuberculosis test prior to their first prescription; any patient who currently has tuberculosis has to undergo anti-tuberculosis treatment before he or she can take Adalimumab. Some patients who do not have tuberculosis at the outset develop it while on this drug.
Children and adolescents who take this drug are at increased risk of lymphoma and other types of cancer. These diseases are often fatal.